Want to see AEMD full AI Analyst Report?
Total Valuation
Aethlon Medical has a market cap or net worth of $1.94M. The enterprise value is -$2.98.
Market Cap$1.94M
Enterprise Value-$2.98
Share Statistics
Aethlon Medical has 711,136 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding711,136
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aethlon Medical’s return on equity (ROE) is -1.46 and return on invested capital (ROIC) is -139.64%.
Return on Equity (ROE)-1.46
Return on Assets (ROA)-1.13
Return on Invested Capital (ROIC)-139.64%
Return on Capital Employed (ROCE)-1.49
Revenue Per Employee0.00
Profits Per Employee-794.61B
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Aethlon Medical is ―. Aethlon Medical’s PEG ratio is 0.01.
PE Ratio―
PS Ratio0.00
PB Ratio1.51
Price to Fair Value1.51
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio0.01
Income Statement
In the last 12 months, Aethlon Medical had revenue of 0.00 and earned -7.15M in profits. Earnings per share was -10.61.
Revenue0.00
Gross Profit0.00
Operating Income-7.29M
Pretax Income-7.15M
Net Income-7.15M
EBITDA-6.81M
Earnings Per Share (EPS)-10.61
Cash Flow
In the last 12 months, operating cash flow was -1.90B and capital expenditures -9.15M, giving a free cash flow of -1.91B billion.
Operating Cash Flow-1.90B
Free Cash Flow-1.91B
Free Cash Flow per Share-2.69K
Dividends & Yields
Aethlon Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.19
52-Week Price Change-96.10%
50-Day Moving Average4.24
200-Day Moving Average10.95
Relative Strength Index (RSI)34.00
Average Volume (3m)688.41K
Important Dates
Aethlon Medical upcoming earnings date is Nov 18, 2026, After Close (Confirmed).
Last Earnings DateAug 13, 2026
Next Earnings DateNov 18, 2026
Ex-Dividend Date―
Financial Position
Aethlon Medical as a current ratio of 3.85, with Debt / Equity ratio of 4.91%
Current Ratio3.85
Quick Ratio3.85
Debt to Market Cap0.00
Net Debt to EBITDA0.69
Interest Coverage Ratio-507.49
Taxes
In the past 12 months, Aethlon Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Aethlon Medical EV to EBITDA ratio is -0.39, with an EV/FCF ratio of >-0.01.
EV to Sales0.00
EV to EBITDA-0.39
EV to Free Cash Flow>-0.01
EV to Operating Cash Flow>-0.01
Balance Sheet
Aethlon Medical has $4.93M in cash and marketable securities with $255.05K in debt, giving a net cash position of $4.68M billion.
Cash & Marketable Securities$4.93M
Total Debt$255.05K
Net Cash$4.68M
Net Cash Per Share$6.58
Tangible Book Value Per Share$7.26
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Aethlon Medical is $1.50, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$1.50
Price Target Upside158.62% Upside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast87.54%